In this podcast, UROONCO PCa associate editor Dr. Giancarlo Marra (IT) talks to Prof. Hashim Ahmed (GB) after his presentation at UROonco23 on focal therapy for low- or intermediate-risk prostate cancer. 

They discuss the main reasons for the change in the new guidelines this year. Prof. Ahmed details the dangers of rapid dissemination. He also shares his expert opinion on how he positions focal therapy within the context of the PROTECT trial results. He concludes with information on other recent focal trials, such as the FARP trial.